|
Symbol
|
RMBQBV | RMA18V | ACXZSQ | AFITTQ | DWFCBL |
|---|---|---|---|---|---|
| Name | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible with European Knock-In | Barrier Reverse Convertible |
|
Underlying
|
Eli Lilly & Co. / Johnson & Johnson / Pfizer Inc. / UnitedHealth Group Inc. | Bristol-Myers Squibb Co. / Johnson & Johnson / Pfizer Inc. / UnitedHealth Group Inc. | LVMH Moet Hennessy Louis Vuitton / Novo Nordisk AS (B) / UnitedHealth Group Inc. | Meta Platforms Inc. / Sika AG / UnitedHealth Group Inc. | Novo Nordisk AS-SPONS ADR / Pfizer Inc. / UnitedHealth Group Inc. |
|
Issuer
|
|
|
|
|
|
|
Date of maturity
|
01.06.2026 | 09.11.2026 | 18.08.2026 | 15.01.2027 | 04.03.2027 |
| Bid | 60.50 | 101.10 | 93.05 | 96.21 | - |
| Ask | - | 102.30 | - | 97.01 | - |